Ph样急性淋巴细胞白血病的分子遗传学改变及其对治疗的意义

doi:10.16150/j.1671-2870.2017.01.006

摘要/Abstract

关键词: Ph样急性淋巴细胞白血病, 分子遗传学改变, 诊断, 机制, 治疗

中图分类号:

R733.7

李佳明, 张苏江. Ph样急性淋巴细胞白血病的分子遗传学改变及其对治疗的意义[J]. 诊断学理论与实践, 2017, 16(01): 27-31.

[1] Jain N, Roberts KG, Jabbour E, et al.Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults[J]. Blood,2017,129(5):572-581.
[2] Roberts KG, Gu Z, Payne-Turner D, et al.High frequency and poor outcome of Philadelphia chromosome-like acute lymphoblastic leukemia in adults[J]. J Clin Oncol,2017,35(4):394-401.
[3] Ge Z, Gu Y, Zhao G, et al.High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement[J]. Oncotarget,2016,7(31):49722-49732.
[4] Chen IM, Harvey RC, Mullighan CG, et al.Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study[J]. Blood,2012,119(15):3512-3522.
[5] Buitenkamp TD, Izraeli S, Zimmermann M, et al.Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group[J]. Blood,2014,123(1):70-77.
[6] Shochat C, Tal N, Gryshkova V, et al.Novel activating mutations lacking cysteine in type I cytokine receptors in acute lymphoblastic leukemia[J]. Blood,2014,124(1):106-110.
[7] Shochat C, Tal N, Bandapalli OR, et al.Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias[J]. J Exp Med,2011,208(5):901-908.
[8] Tal N, Shochat C, Geron I, et al.Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia[J]. Cell Mol Life Sci,2014,71(3):365-378.
[9] Roberts KG, Li Y, Payne-Turner D, et al.Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia[J]. N Engl J Med,2014,371(11):1005-1015.
[10] Tran TH, Loh ML.Ph-like acute lymphoblastic leukemia[J]. Hematology Am Soc Hematol Educ Program,2016, 2(1):561-566.
[11] Loh ML, Zhang J, Harvey RC, et al.Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project[J]. Blood,2013,121(3):485-488.
[12] Tasian SK, Teachey DT, Li Y, et al.Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia[J]. Blood,2017,129(2):177-187.
[13] Maude SL, Tasian SK, Vincent T, et al.Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia[J]. Blood,2012,120(17):3510-3518.
[14] Churchman ML, Mullighan CG.Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia[J]. Exp Hematol,2017, 46:1-8.
[15] Stadt UZ, Escherich G, Indenbirken D, et al.Rapid capture next-generation sequencing in clinical diagnostics of kinase pathway aberrations in B-cell precursor aLL[J]. Pediatr Blood Cancer,2016,63(7):1283-1286.
[16] Dörge P, Meissner B, Zimmermann M, et al.IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol[J]. Haematologica,2013,98(3):428-432.
[17] Yano M, Imamura T, Asai D, et al.Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with IKZF1 deletion[J]. Br J Haematol,2015,171(5):813-817.
[18] Morak M, Attarbaschi A, Fischer S, et al.Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL[J]. Blood,2012,120(26):5134-5142.
[19] Zhao C, Khadka DB, Cho WJ.Insights into the structural features essential for JAK2 inhibition and selectivity[J]. Curr Med Chem,2016,23(13):1331-1355.
[20] Waibel M, Solomon VS, Knight DA, et al.Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitors[J]. Cell Rep,2013,5(4):1047-1059.
[21] Koppikar P, Bhagwat N, Kilpivaara O, et al.Hete-rodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy[J]. Nature,2012,489(7414):155-159.
[22] Sakamoto K, Imamura T, Kanayama T, et al. Ph-like acute lymphoblastic leukemia with a novel PAX5-KIDINS220 fusion transcript[J/OL]. Genes Chromosomes Cancer,2016-11-07[2017-02-10].https://www.ncbi.nlm.nih.gov/pubmed/27870151.
[23] Marincevic-Zuniga Y, Zachariadis V, Cavelier L, et al.PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia[J]. Haematologica,2016,101(1):e20-e23.
[24] Louria-Hayon I, Frelin C, Ruston J, et al.Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling[J]. Proc Natl Acad Sci U S A,2013,110(51):20599-20604.
[25] Schwab C, Ryan SL, Chilton L, et al.EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications[J]. Blood,2016,127(18):2214-2218.
[26] Ishibashi T, Yaguchi A, Terada K, et al.Ph-like ALL-related novel fusion kinase ATF7IP-PDGFRB exhibits high sensitivity to tyrosine kinase inhibitors in murine cells[J]. Exp Hematol,2016,44(3):177-188.
[27] Kobayashi K, Miyagawa N, Mitsui K, et al.TKI dasatinib monotherapy for a patient with Ph-like ALL bearing ATF7IP/PDGFRB translocation[J]. Pediatr Blood Cancer,2015,62(6):1058-1060.

Ph样急性淋巴细胞白血病的分子遗传学改变及其对治疗的意义

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	何亲羽, 王伟, 陈立芬, 张雪蕾, 董治亚. LHCGR基因突变致家族性男性性早熟2例报告及文献复习[J]. 诊断学理论与实践, 2022, 21(05): 598-605.
[2]	陈志敏, 何浩岚. 艾滋病合并马尔尼菲篮状菌病的诊治现状[J]. 诊断学理论与实践, 2022, 21(04): 425-430.
[3]	沈银忠. 《人类免疫缺陷病毒感染/艾滋病合并结核分枝杆菌感染诊治专家共识》解读[J]. 诊断学理论与实践, 2022, 21(04): 431-436.
[4]	施霞, 马鑫, 王珍燕, 张晖, 刘少军. 32例人类免疫缺陷病毒感染合并慢性肾病患者的临床病理特征及随访结果分析[J]. 诊断学理论与实践, 2022, 21(04): 437-443.
[5]	陈宏, 沈银忠. 人类免疫缺陷病毒感染/艾滋病合并结核病的诊治进展[J]. 诊断学理论与实践, 2022, 21(04): 530-534.
[6]	何新, 陈慧, 冯炜炜. 机器学习算法在辅助超声诊断附件肿块良恶性中的应用研究进展[J]. 诊断学理论与实践, 2022, 21(04): 541-546.
[7]	徐子真, 李擎天, 刘湘帆, 李莉, 李惠, 王也飞, 吴洁敏, 陈宁, 梁璆荔, 陈松立, 戴健敏, 宋珍, 丁磊. 实验诊断学在线课程的建立和实践[J]. 诊断学理论与实践, 2022, 21(04): 547-550.
[8]	汤建平, 龚邦东. 干燥综合征的诊治现状、挑战和思考[J]. 诊断学理论与实践, 2022, 21(03): 291-298.
[9]	李佳, 吕良敬. 靶向治疗时代议自身免疫病的感染挑战[J]. 诊断学理论与实践, 2022, 21(03): 299-303.
[10]	赵然, 詹维伟, 侯怡卿. 计算机辅助诊断系统辅助超声诊断甲状腺弥漫性病变合并结节良恶性的应用价值[J]. 诊断学理论与实践, 2022, 21(03): 390-394.
[11]	郭业兵, 郑金峰. 阴道壁胃肠道外间质瘤一例报道并文献复习[J]. 诊断学理论与实践, 2022, 21(03): 405-407.
[12]	中华医学会内分泌学分会. 新型冠状病毒肺炎疫情下骨质疏松症管理专家建议[J]. 诊断学理论与实践, 2022, 21(02): 133-135.
[13]	王刚, 陈生弟. 神经病学的诊断：起源、发展及挑战[J]. 诊断学理论与实践, 2022, 21(01): 1-4.
[14]	唐静仪, 余群, 刘军. 结合人工智能的结构影像分析对阿尔茨海默病的早期预测及精准诊断研究进展[J]. 诊断学理论与实践, 2022, 21(01): 12-17.
[15]	魏文石. 直面我国阿尔茨海默病诊治的挑战——《中国阿尔茨海默病报告2021》解读[J]. 诊断学理论与实践, 2022, 21(01): 5-7.